Mirai Bio
The first open end-to-end platform for genetic medicines
Cambridge, United States · $50.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Website
- miraibio.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series ASep 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Machine intelligence-based open platform for end-to-end genetic medicine development, enabling delivery to any tissue and cell type.
Summary
Mirai Bio is an Artificial Intelligence company based in Cambridge, United States. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in Sep 2024. Investors include Flagship Pioneering.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2024
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Databricks provides a unified data and AI platform that helps enterprises build and run applicati...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/mirai-bio"><img src="https://indexed.vc/api/badge/company/mirai-bio" alt="Mirai Bio on Indexed.vc" width="260" height="76" /></a>